These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A prediction model for bacterial etiology in acute exacerbations of COPD. Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M Infection; 2007 Jun; 35(3):143-9. PubMed ID: 17565454 [TBL] [Abstract][Full Text] [Related]
24. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic. File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762 [TBL] [Abstract][Full Text] [Related]
25. [Antibacterial therapy in exacerbation of chronic obstructive bronchitis]. Sinopal'nikov AI; Fesenko OV Klin Med (Mosk); 1998; 76(9):15-20. PubMed ID: 9821367 [No Abstract] [Full Text] [Related]
26. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study. Deal EN; Micek ST; Reichley RM; Ritchie DJ Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902 [TBL] [Abstract][Full Text] [Related]
27. [Inhalational antibiotic therapy in patients with cystic fibrosis and Pseudomonas infection]. Mordasini C; Aebischer CC; Schoch OD Schweiz Med Wochenschr; 1997 May; 127(21):905-10. PubMed ID: 9289818 [TBL] [Abstract][Full Text] [Related]
32. [Pseudomonas spp from hospitals: typing and sensitivity to antibiotics]. Nazzari C; Mancini C; Brenciaglia MI; Giordano A; Cipriani P G Ital Chemioter; 1985; 32(1):203-6. PubMed ID: 3830779 [No Abstract] [Full Text] [Related]
33. Antibacterial therapy of acute infectious exacerbation of chronic obstructive pulmonary disease. Chelidze K; Jgarkava M Georgian Med News; 2008 Jun; (159):27-30. PubMed ID: 18633147 [TBL] [Abstract][Full Text] [Related]
34. [Antibiotic resistance of some Pseudomonas aeruginosa isolates]. Matinca D; Vancea D; Boboş C; Serban O Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333 [No Abstract] [Full Text] [Related]
35. Clinical predictors of bacterial involvement in exacerbations of chronic obstructive pulmonary disease. van der Valk P; Monninkhof E; van der Palen J; Zielhuis G; van Herwaarden C; Hendrix R Clin Infect Dis; 2004 Oct; 39(7):980-6. PubMed ID: 15472849 [TBL] [Abstract][Full Text] [Related]
36. Activity of selected antimicrobial agents against the Pseudmonas pseudomallei infection of mice. Grunberg E; Beskid G; Delorenzo WF; Titsworth E Am Rev Respir Dis; 1970 Apr; 101(4):623-6. PubMed ID: 5439884 [No Abstract] [Full Text] [Related]
37. [Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: analysis of comparative trials]. Garré M; Garo B; Ansart S; Le Berre R Med Mal Infect; 2006; 36(11-12):690-6. PubMed ID: 16824719 [TBL] [Abstract][Full Text] [Related]
38. Role of antibacterial chemotherapy in the management of chronic bronchial obstructive disease. Gialdroni-Grassi G Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):431-6. PubMed ID: 7203719 [TBL] [Abstract][Full Text] [Related]